Going to be interesting what happens after FDA approval's especially with Mithra on board with their huge stake in Mayne together with a another long time ( 2017) key stakeholder whom I'm certain would know exactly what changes maybe are necessary and in a position to fix them . We've already seen the departure of our CFO ( usual family reasons given) If there needs to be some changes at the top pretty certain they'll be fixed not too far down the track and hopefully shareholder growth taken more into account not just Company growth .
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.08 |
Change
0.010(0.20%) |
Mkt cap ! $412.7M | |||
| Open | High | Low | Value | Volume |
| $5.13 | $5.15 | $5.08 | $445.2K | 87.01K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 810 | $5.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.15 | 2033 | 2 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| MYX (ASX) Chart |